Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zomedica Pharmaceuticals Corp (NY: ZOM )

0.1202 UNCHANGED
Official Closing Price Updated: 8:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zomedica Pharmaceuticals Corp

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Zomedica Stock Has More Headwinds Than the Rest of the Pet Industry
Drilling into pet industry details reveals a key risk factor that some ZOM stock believers may be ignoring. 
Via InvestorPlace
Risk-Reward Ratio of Zomedica Stock Looks Unfavorable
Zomedica may be facing tough competition, and there are indications that Truforma is not popular so far. ZOM stock looks very risky. 
Via InvestorPlace
Zomedica Pharmaceuticals Has to Prove Itself to Long-Term Investors
The hype surrounding ZOM stock has worn off, and it's now time for the company to prove its value through its sales numbers. 
Via InvestorPlace
Zomedica Is Good Value and May Be Worth $1.36 — Or More
Zomedica is good value and is on the acquisition warpath. ZOM stock is worth $1.36 on average, providing an average 20% ROI over 2 years. 
Via InvestorPlace
Zomedica Is Surprisingly Cheap Even as Commercialization Commences
ZOM stock has spiked sharply this year, but a recent price pullback could signal an ideal entry point for pet care market investors. 
Via InvestorPlace
Better Robinhood Penny Stock: Sundial Growers vs. Zomedica
Both have been huge winners in recent months. 
Via The Motley Fool
Zomedica’s Risks Are Too Big to Ignore
You may like ZOM stock as a pet lover, but not for its fundamentals, nor its valuation until it starts having credible financial results. 
Via InvestorPlace
Zomedica’s High Share Count Creates Challenges for ZOM Stock
Zomedica has promising growth potential, but its high share count makes ZOM stock a risky investment. Here's what investors should know. 
Via InvestorPlace
Topics Bonds
Exposures Debt Markets
Zomedica Stock Will Be Worth The Risk After Another Drop
Another pullback in ZOM stock will put this long-term speculative play's odds in your favor if its Truforma product catches on. 
Via InvestorPlace
Right-Priced Zomedica Could Be an Investor’s Best Friend
The skeptics might misinterpret the company's first-quarter revenue data, but a deeper dive should uncover reasons to hold on to ZOM stock. 
Via InvestorPlace
Exposures COVID-19
Social Distancing Creates Pet-Buying Boom that Sends the Industry to New Heights
Via FinancialNewsMedia
Bets on Zomedica’s In-Office Vet Test Could Payoff or Bust by Year-End
ZOM stock is pure speculation as pet owners are spending more on keeping their dogs and cats alive. 
Via InvestorPlace
Is Zomedica Making a Change For the Better?
Wait for evidence of success before making a speculative bet on ZOM stock 
Via InvestorPlace
Zomedica Stock Can Return to a Dollar If It Focuses on Just One Thing
Zomedica is testing its support levels at current prices. What does the maker of diagnostic equipment need to do to get ZOM stock back to $1? 
Via InvestorPlace
Zomedica Stock Is At Serious Risk Unless Bulls Commit
ZOM stock makes for a better trading vehicle than an investment in spite of their noble effort to heal. It needs to hold recent lows or else. 
Via InvestorPlace
Could Zomedica Be a Millionaire-Maker Stock?
Or will speculation lead to major disappointment? 
Via The Motley Fool
Why Zomedica Stock Popped Today
A new executive will oversee the company's growth initiatives. 
Via The Motley Fool
Zomedica Stock Will Burn You as High-Growth Stocks Start to Flag
The bull market has certainly made new investors look like geniuses, as usual. But now is the true test and ZOM stock isn't likely to pass. 
Via InvestorPlace
Zomedica Stock Is Clearly Going to Keep Moving in the Wrong Direction
Zom stock is sliding downward due to its precarious financial situation. With no sales, it's best for investors to steer clear. 
Via InvestorPlace
Zomedica Is Now a Low-Probability Gamble
ZOM stock attracts plenty of attention for its underlying pet care business and its wild potential but this game may be over. 
Via InvestorPlace
Zomedica Stock Is Another Hyped-Up Reddit Play That Can’t Escape Reality
Zomedica has potential in a niche business. But the price of ZOM stock does not yet reflect that. This will change as day traders move on. 
Via InvestorPlace
Are Penny Stocks A Solution To Inflation?
Inflationary fears are back in the news cycle but is that bad for all stocks? 
Via Talk Markets
Why Zomedica Stock Isn’t Worth Buying Right Now
If Truforma truly is a game-changer, there’s hope the company could grab part of a potential $10.5 billion animal diagnostics market. 
Via InvestorPlace
3 Reddit Stocks In Meltdown Mode: Is A Rally On The Horizon?
Stocks are always doing one of three things: Moving higher, moving lower or staying the same. When they're moving higher the bulls (buyers) control the market.... 
Via Benzinga
Zomedica: After a Wild Winter, It’s Back to Business
While ZOM stock has been highly volatile, the business is progressing. The Truforma platform has launched and we'll start seeing revenue figures soon. 
Via InvestorPlace
Investor Impatience Will Send Zomedica Stock Back Below a Dollar
Zomedica may be worth a gamble at some point, but for now you can expect ZOM stock to continue falling well below $1 per share. 
Via InvestorPlace
Why Zomedica Is a Great Speculative Play Right Now
ZOM stock makes as much sense as it ever has right now. Truforma's best days are in front of it which is also true of Zomedica shares. 
Via InvestorPlace
Sales Model Shift Should Provide a Long-Term Boost for Zomedica
ZOM stock has pulled back sharply from its peak price, but Zomedica has an opportunity as it seeks to expand its market presence. 
Via InvestorPlace
Exposures COVID-19
Zomedica Stock Is Very Attractive Here As Its New Product Launch Takes Off
ZOM stock is very attractive today, currently well below its target value of $1.63 and assuming it takes 10% of the pet diagnostic market. 
Via InvestorPlace
Why Zomedica Stock is a Pure Gamble Right Now
ZOM stock double peaked last month before falling sharply, as investors await for the Truforma launch to pay off handsomely. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.